Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release Formulation

Inclusion Criteria: * 19\~44 aged healthy adult. * someone tho has at least 50kg body weight and ideal body weight ±20% Exclusion Criteria: * someone has acute symptom at screening phase * someone has any disease or symptoms which is clinically significant * someone had been determined during healthy examination in screening period * AST or ALT \> 1.25 times than normal * Total bilirubin \> 1.5 times than normal * someone who has a history of allergy, anaphylaxis, drug abuse or misuse. * someone who had enrolled to other clinical trial within the last 60 days. * someone who had donated blood within the last 60 days. * someone who can't take a meal derived from this trial. * someone who has taken abnormal meals like which can affect to drug ADME * someone who has taken other ETC drugs or oriental drugs within the last 14 days, Or OTC drugs within the last 7 days * someone who has taken caffein continuously (coffee or green tea more than 5 cups per a day) or took caffein since 24hours before. * someone who has taken alcohol more than 30g/day or smoked more than 10 piece of tobacco/day. * someone who has galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.